LUMIGAN Side Effects

7017931-9 | Myalgia
on Sep 17, 2010 Male patient from GERMANY , 77 years of age, was diagnosed with cardiovascular disorder, chronic obstructive pulmonary disease and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: myalgia. Lumigan dosage: Unk. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VIANI FORTE (View Viani Forte Review and Viani Forte Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), SALBUTAMOL (Unk) (View Salbutamol Review and Salbutamol Label ), PREDNISONE (20 Mg, Unk) (View Prednisone Review and Prednisone Label ), BETA ACETYLDIGOXIN (View Beta-acetyldigoxin Review and Beta-acetyldigoxin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMID (40 Mg, Unk) (View Furosemid Review and Furosemid Label ).

7017930-7 | Chemical Burns Of Eye
Patient was taking Lumigan (View Usage). Patient had the following side effects: chemical burns of eye on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with open angle glaucoma and. Lumigan dosage: 1 Gtt, Qhs. During the same period patient was treated with PRESERVATIVE FREE TIMOLOL (View Preservative Free Timolol Review and Preservative Free Timolol Label ).

6961814-7 | Myalgia
Adverse event was reported on Aug 24, 2010 by a Male patient taking Lumigan (View Usage) (Dosage: Unk) was diagnosed with cardiovascular disorder, chronic obstructive pulmonary disease and. Location: GERMANY , 77 years of age, After Lumigan was administered, patient had the following side effects: myalgia. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VIANI FORTE (View Viani Forte Review and Viani Forte Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ALBUTEROL SULFATE AUTOHALER (Unk) (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), PREDNISONE (20 Mg, Unk) (View Prednisone Review and Prednisone Label ), BETA ACETYLDIGOXIN (View Beta-acetyldigoxin Review and Beta-acetyldigoxin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMID (40 Mg, Unk) (View Furosemid Review and Furosemid Label ).

6911769-6 | Intraocular Pressure Increased
on Aug 05, 2010 Male patient from JAPAN , 57 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure increased. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with CARTEOLOL HYDROCHLORIDE (1 Gtt, Bid) (View Carteolol Hydrochloride Review and Carteolol Hydrochloride Label ), BRINZOLAMIDE (Unk) (View Brinzolamide Review and Brinzolamide Label ), ACETAZOLAMIDE (Unk) (View Acetazolamide Review and Acetazolamide Label ), POTASSIUM GLUCONATE TAB (Unk) (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), FLUMETHOLON (Unk) (View Flumetholon Review and Flumetholon Label ), LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ).


6911763-5 | Eye Pain, Headache, Hyphaema
on Aug 05, 2010 Male patient from JAPAN , 27 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient had the following side effects: eye pain, headache (What is headache?), hyphaema. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with PILOCARPINE HCL (Unk) (View Pilocarpine Hcl Review and Pilocarpine Hcl Label ), DORZOLAMIDE HYDROCHLORIDE (Unk) (View Dorzolamide Hydrochloride Review and Dorzolamide Hydrochloride Label ), HYALURONATE SODIUM (Unk) (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ), GLUTATHIONE (Unk) (View Glutathione Review and Glutathione Label ), TIMOLOL MALEATE (Unk) (View Timolol Maleate Review and Timolol Maleate Label ), ACETAZOLAMIDE (Unk) (View Acetazolamide Review and Acetazolamide Label ), ASPARTATE POTASSIUM (Unk) (View Aspartate Potassium Review and Aspartate Potassium Label ).

6835891-8 | Retinal Haemorrhage, Retinal Vein Thrombosis
Patient was taking Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: retinal haemorrhage, retinal vein thrombosis on Jul 06, 2010 from POLAND Additional patient health information: Female patient , 51 years of age, was diagnosed with ocular hypertension, pseudoexfoliation of lens capsule and. Lumigan dosage: Unk.

6831959-0 | Intraocular Pressure Increased, Visual Acuity Reduced, Vitreous Haemorrhage
Adverse event was reported on May 20, 2010 by a Male patient taking Lumigan (View Usage) (Dosage: 1 Gtt, Qd) was diagnosed with glaucoma (What is glaucoma?) and. Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: intraocular pressure increased, visual acuity reduced, vitreous haemorrhage. During the same period patient was treated with LATANOPROST (Unk) (View Latanoprost Review and Latanoprost Label ), RYSMON TG (1 Gtt, Qd) (View Rysmon Tg Review and Rysmon Tg Label ), AZOPT (1 Gtt, Bid) (View Azopt Review and Azopt Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), POTASSIUM L ASPARTATE (View Potassium L-aspartate Review and Potassium L-aspartate Label ).

6828436-X | Lip Swelling, Rash
on Jul 08, 2010 Female patient from UNITED STATES , 65 years of age, weighting 185.0 lb, was diagnosed with intraocular pressure increased and was treated with Lumigan (View Usage). Patient had the following side effects: lip swelling, rash (What is rash?). Lumigan dosage: 1 Drop Per Eye Nightly.

6810161-2 | Macular Oedema
on May 28, 2010 Female patient from JAPAN , 85 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: macular oedema. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with TRUSOPT (1 Gtt, Bid) (View Trusopt Review and Trusopt Label ), KARY UNI (Unk) (View Kary Uni Review and Kary Uni Label ), RESCULA (Unk) (View Rescula Review and Rescula Label ), LIPITOR (View Lipitor Review and Lipitor Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BLOPRESS (View Blopress Review and Blopress Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6795291-6 | Retinal Haemorrhage, Retinal Vein Thrombosis
Patient was taking Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: retinal haemorrhage, retinal vein thrombosis on Jun 18, 2010 from POLAND Additional patient health information: Female patient , 51 years of age, was diagnosed with ocular hypertension, pseudoexfoliation of lens capsule and. Lumigan dosage: Unk.

6773658-X | Deformity, Emotional Disorder, Eyelid Disorder, Lipoatrophy
Adverse event was reported on Jun 15, 2010 by a Male patient taking Lumigan (View Usage) (Dosage: One Drop Bid Ophthalmic) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 79 years of age, weighting 180.0 lb, Patient had the following side effects: deformity, emotional disorder, eyelid disorder, lipoatrophy.

6771310-8 | Vitreous Haemorrhage
on May 27, 2010 Male patient from JAPAN , 62 years of age, was diagnosed with open angle glaucoma and was treated with Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: vitreous haemorrhage. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with CARBAZOCHROME SODIUM SULFONATE (Unk) (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ), KALLIDINOGENASE (Unk) (View Kallidinogenase Review and Kallidinogenase Label ).

6766654-X | Intraocular Pressure Increased, Vitreous Haemorrhage
on May 20, 2010 Male patient from JAPAN , 71 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure increased, vitreous haemorrhage. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with LATANOPROST (Unk) (View Latanoprost Review and Latanoprost Label ), RYSMON TG (1 Gtt, Qd) (View Rysmon Tg Review and Rysmon Tg Label ), AZOPT (1 Gtt, Bid) (View Azopt Review and Azopt Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), POTASSIUM L ASPARTATE (View Potassium L-aspartate Review and Potassium L-aspartate Label ).

6766651-4 | Intraocular Pressure Increased
Patient was taking Lumigan (View Usage). Patient had the following side effects: intraocular pressure increased on May 20, 2010 from JAPAN Additional patient health information: Female patient , 16 years of age, was diagnosed with glaucoma (What is glaucoma?), infection (What is infection?) and. Lumigan dosage: 1 Gtt, Unk. During the same period patient was treated with BRINZOLAMIDE (Unk) (View Brinzolamide Review and Brinzolamide Label ), CARTEOLOL HYDROCHLORIDE (Unk) (View Carteolol Hydrochloride Review and Carteolol Hydrochloride Label ), ACETAZOLAMIDE (Unk) (View Acetazolamide Review and Acetazolamide Label ), POTASSIUM L ASPARTATE (Unk) (View Potassium L-aspartate Review and Potassium L-aspartate Label ), LATANOPROST (Unk) (View Latanoprost Review and Latanoprost Label ), ECOLICIN (Unk) (View Ecolicin Review and Ecolicin Label ).

6737707-7 | Optic Atrophy, Therapeutic Response Decreased
Adverse event was reported on May 12, 2010 by a Male patient taking Lumigan (View Usage) (Dosage: 1 Gtt, Qd) was diagnosed with open angle glaucoma and. Location: JAPAN , 78 years of age, After Lumigan was administered, patient had the following side effects: optic atrophy, therapeutic response decreased. During the same period patient was treated with CARTELOL (Unk) (View Cartelol Review and Cartelol Label ), DORZOLAMIDE (Unk) (View Dorzolamide Review and Dorzolamide Label ), LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ), FLUOROMETHOLONE (Unk) (View Fluorometholone Review and Fluorometholone Label ).

6681602-9 | Eyelid Disorder
on Apr 13, 2010 Male patient from UNITED STATES , 79 years of age, weighting 180.0 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: eyelid disorder. Lumigan dosage: One Drop In Right Eye Nightly Top.

6651353-5 | Eye Pain, Headache, Hyphaema
on Mar 17, 2010 Male patient from JAPAN , 27 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient had the following side effects: eye pain, headache (What is headache?), hyphaema. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with PILOCARPINE HCL (Unk) (View Pilocarpine Hcl Review and Pilocarpine Hcl Label ), DORZOLAMIDE HYDROCHLORIDE (Unk) (View Dorzolamide Hydrochloride Review and Dorzolamide Hydrochloride Label ), HYALURONATE SODIUM (Unk) (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ), GLUTATHIONE (Unk) (View Glutathione Review and Glutathione Label ), TIMOLOL MALEATE (Unk) (View Timolol Maleate Review and Timolol Maleate Label ), ACETAZOLAMIDE (Unk) (View Acetazolamide Review and Acetazolamide Label ), ASPARTATE POTASSIUM (Unk) (View Aspartate Potassium Review and Aspartate Potassium Label ).

6634286-X | Intraocular Pressure Increased
Patient was taking Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: intraocular pressure increased on Mar 05, 2010 from JAPAN Additional patient health information: Male patient , 57 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with CARTEOLOL HYDROCHLORIDE (1 Gtt, Bid) (View Carteolol Hydrochloride Review and Carteolol Hydrochloride Label ), BRINZOLAMIDE (Unk) (View Brinzolamide Review and Brinzolamide Label ), ACETAZOLAMIDE (Unk) (View Acetazolamide Review and Acetazolamide Label ), POTASSIUM GLUCONATE TAB (Unk) (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), FLUMETHOLON (Unk) (View Flumetholon Review and Flumetholon Label ), LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ).

6618645-7 | Dry Eye, Eye Pain, Hair Colour Changes, Hair Texture Abnormal, Madarosis, No Therapeutic Response
Adverse event was reported on Mar 05, 2010 by a Female patient taking Lumigan (View Usage) (Dosage: 1 Drop Each Eye Morning/night Many Years) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , weighting 126.0 lb, Patient experienced the following unwanted or unexpected effects: dry eye, eye pain, hair colour changes, hair texture abnormal, madarosis, no therapeutic response. During the same period patient was treated with TEARS (View Tears Review and Tears Label ), LATISSE (View Latisse Review and Latisse Label ).

6614582-2 | Blepharitis, Blepharospasm, Dry Eye, Dry Skin, Eye Discharge, Eyelid Oedema, Growth Of Eyelashes, Insomnia, Muscle Twitching
on Mar 04, 2010 Female patient from UNITED STATES , 56 years of age, weighting 154.0 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient had the following side effects: blepharitis, blepharospasm, dry eye, dry skin, eye discharge, eyelid oedema, growth of eyelashes, insomnia, muscle twitching. Lumigan dosage: One Drop In Each Eye Nightly Opthalmic.

6611627-0 | Fall
on Feb 18, 2010 Female patient from JAPAN , 72 years of age, was diagnosed with open angle glaucoma and was treated with Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: fall (What is fall?). Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with PIRENOXINE (Unk) (View Pirenoxine Review and Pirenoxine Label ), MECOBALAMIN (Unk) (View Mecobalamin Review and Mecobalamin Label ), HYALURONATE SODIUM (Unk) (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ).

6577434-2 | Abdominal Pain, Dyspnoea, Hypotension, Malaise
Patient was taking Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dyspnoea, hypotension, malaise on Feb 09, 2010 from FRANCE Additional patient health information: Female patient , 31 years of age, . Lumigan dosage: Unk. During the same period patient was treated with TIMOPTOL (Unk) (View Timoptol Review and Timoptol Label ), DRILL PASTILLE (View Drill Pastille Review and Drill Pastille Label ), EUPHON SYRUP (View Euphon Syrup Review and Euphon Syrup Label ). Patient was hospitalized.

6577433-0 | Endophthalmitis, Ulcerative Keratitis
Adverse event was reported on Feb 04, 2010 by a Male patient taking Lumigan (View Usage) (Dosage: 1 Gtt, Qd) was diagnosed with glaucoma (What is glaucoma?) and. Location: JAPAN , 92 years of age, Patient had the following side effects: endophthalmitis, ulcerative keratitis. During the same period patient was treated with BIMATOPROST (Unk) (View Bimatoprost Review and Bimatoprost Label ). Patient was hospitalized.

6565971-6 | Abdominal Pain, Dyspnoea, Hypotension, Malaise
on Jan 20, 2010 Female patient from FRANCE , 31 years of age, was treated with Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), dyspnoea, hypotension, malaise. Lumigan dosage: Unk. During the same period patient was treated with TIMOPTIC (Unk) (View Timoptic Review and Timoptic Label ), DRILL PASTILLE (View Drill Pastille Review and Drill Pastille Label ), EUPHON SYRUP (View Euphon Syrup Review and Euphon Syrup Label ). Patient was hospitalized.

6565856-5 | Endophthalmitis, Ulcerative Keratitis
on Jan 18, 2010 Female patient from JAPAN , 90 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis, ulcerative keratitis. Lumigan dosage: 1 Gtt, Single. Patient was hospitalized.

6542838-0 | No Adverse Event
Patient was taking Lumigan (View Usage). Patient had the following side effects: no adverse event on Jan 14, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 190.0 lb, was diagnosed with glaucoma (What is glaucoma?) and. Lumigan dosage: Unk. During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), CIALIS (Unk) (View Cialis Review and Cialis Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), VITAMINS (Unk) (View Vitamins Review and Vitamins Label ), WARFARIN (Unk) (View Warfarin Review and Warfarin Label ).

6499030-8 | Prostate Cancer
Adverse event was reported on Dec 07, 2009 by a Male patient taking Lumigan (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 65 years of age, weighting 190.0 lb, After Lumigan was administered, patient had the following side effects: prostate cancer (What is prostate cancer?). During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), CIALIS (Unk) (View Cialis Review and Cialis Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), VITAMINS (Unk) (View Vitamins Review and Vitamins Label ), WARFARIN SODIUM (Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6479526-5 | Hair Growth Abnormal, Skin Discolouration
on Dec 07, 2009 Female patient from UNITED STATES , weighting 220.0 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: hair growth abnormal, skin discolouration. Lumigan dosage: One Drop In Each Ey Once A Day At Nigh.

6463606-4 | Ulcerative Keratitis
on Nov 13, 2009 Female patient from JAPAN , 79 years of age, was diagnosed with ocular hypertension and was treated with Lumigan (View Usage). Patient had the following side effects: ulcerative keratitis. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with TEARBALANCE (Unk) (View Tearbalance Review and Tearbalance Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ), TIMOPTOL XE (Unk) (View Timoptol Xe Review and Timoptol Xe Label ), RIZABEN (Unk) (View Rizaben Review and Rizaben Label ). Patient was hospitalized and became disabled.

6440802-3 | Ulcerative Keratitis
Patient was taking Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: ulcerative keratitis on Nov 06, 2009 from JAPAN Additional patient health information: Female patient , 79 years of age, was diagnosed with ocular hypertension and. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with TEARBALANCE (Unk) (View Tearbalance Review and Tearbalance Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ), TIMOPTOL XE (Unk) (View Timoptol Xe Review and Timoptol Xe Label ), RIZABEN (Unk) (View Rizaben Review and Rizaben Label ).

6417002-6 | Asthenopia, Fatigue
Adverse event was reported on Sep 23, 2009 by a Female patient taking Lumigan (View Usage) (Dosage: 1 Gtt, Qhs) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 87 years of age, Patient experienced the following unwanted or unexpected effects: asthenopia, fatigue. During the same period patient was treated with ALPHAGAN P (1 Gtt, Bid) (View Alphagan P Review and Alphagan P Label ).

6416986-X | Eyelid Exfoliation, Skin Discolouration
on Jul 31, 2009 Female patient from UNITED STATES , 80 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient had the following side effects: eyelid exfoliation, skin discolouration. Lumigan dosage: . During the same period patient was treated with ALPHAGAN (View Alphagan Review and Alphagan Label ).

6408096-2 | Retinal Vein Occlusion
on Oct 15, 2009 Male patient from UNITED KINGDOM , 47 years of age, weighting 154.3 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: retinal vein occlusion. Lumigan dosage: 1 Gtt, Qpm. During the same period patient was treated with COMBIGAN (Unk) (View Combigan Review and Combigan Label ), AZOPT (Unk) (View Azopt Review and Azopt Label ).

6376364-9 | Intraocular Pressure Increased
Patient was taking Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure increased on Sep 18, 2009 from AUSTRALIA Additional patient health information: Female patient , 58 years of age, was diagnosed with glaucoma (What is glaucoma?), asthma (What is asthma?) and. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with ALPHAGAN (1 Gtt, Tid) (View Alphagan Review and Alphagan Label ), AZOPT (1 Gtt, Tid) (View Azopt Review and Azopt Label ), SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ).

6376348-0 | Macular Oedema
Adverse event was reported on Sep 23, 2009 by a Male patient taking Lumigan (View Usage) (Dosage: Unk) was diagnosed with pigmentary glaucoma and. Location: GERMANY , 49 years of age, Patient had the following side effects: macular oedema.

6346425-9 | Acne, Blister, Eye Discharge
on Sep 04, 2009 Female patient from CANADA , 89 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: acne (What is acne?), blister, eye discharge. Lumigan dosage: 1 Gtt, Qd.

6345305-2 | Headache
on Sep 02, 2009 Female patient from CANADA , 86 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?). Lumigan dosage: 1 Gtt, Qd.

6339103-3 | Asthma, Bronchospasm, Lung Cyst
Patient was taking Lumigan (View Usage). Patient had the following side effects: asthma (What is asthma?), bronchospasm, lung cyst on Aug 31, 2009 from CANADA Additional patient health information: Female patient , 74 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Lumigan dosage: 1 Gtt, Qhs.

6339043-X | Cataract, Lacrimation Increased, Visual Acuity Reduced
Adverse event was reported on Aug 31, 2009 by a Female patient taking Lumigan (View Usage) (Dosage: 1 Gtt, Qhs) was diagnosed with glaucoma (What is glaucoma?) and. Location: CANADA , 82 years of age, After Lumigan was administered, patient had the following side effects: cataract (What is cataract?), lacrimation increased, visual acuity reduced.

6334490-4 | Macular Oedema
on Aug 24, 2009 Male patient from GERMANY , 49 years of age, was diagnosed with pigmentary glaucoma and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: macular oedema. Lumigan dosage: Unk.

6330499-5 |
on Aug 25, 2009 Male patient from UNITED STATES , 87 years of age, was treated with Lumigan (View Usage). . Lumigan dosage: Unk. During the same period patient was treated with ALPHAGAN P (Unk) (View Alphagan P Review and Alphagan P Label ).

6329521-1 | Blepharitis, Dry Eye, Eye Discharge, Pigmentation Disorder, Skin Irritation
Patient was taking Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: blepharitis, dry eye, eye discharge, pigmentation disorder, skin irritation on Aug 25, 2009 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 110.0 lb, was diagnosed with glaucoma (What is glaucoma?) and. Lumigan dosage: One Drop Daily.

6310937-4 |
Adverse event was reported on Aug 12, 2009 by a Male patient taking Lumigan (View Usage) (Dosage: Unk) . Location: UNITED STATES , 87 years of age, . During the same period patient was treated with ALPHAGAN P (Unk) (View Alphagan P Review and Alphagan P Label ).

6308755-6 | Dry Eye
on Jun 04, 2008 Male patient from UNITED STATES , 80 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient had the following side effects: dry eye. Lumigan dosage: Unk, Qhs. During the same period patient was treated with COMBIGAN (Unk, Bid) (View Combigan Review and Combigan Label ).

6293419-8 | Choroidal Detachment
on Jul 28, 2009 Male patient from UNITED KINGDOM , 75 years of age, weighting 165.3 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: choroidal detachment. Lumigan dosage: 1 Gtt, Qpm. During the same period patient was treated with COMBIGAN (Unk, Bid) (View Combigan Review and Combigan Label ), TRUSOPT (Unk, Bid) (View Trusopt Review and Trusopt Label ).

6286053-7 | Amnesia, Eczema, Headache, Nightmare, Paraesthesia, Rash
Patient was taking Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, eczema (What is eczema?), headache (What is headache?), nightmare, paraesthesia, rash (What is rash?) on Jul 23, 2009 from DENMARK Additional patient health information: Female patient , 82 years of age, weighting 169.8 lb, was diagnosed with glaucoma (What is glaucoma?), blood pressure (What is blood pressure?), electrolyte imbalance and. Lumigan dosage: 1 Gtt, Qd. During the same period patient was treated with ATACAND (8 Mg, Unk) (View Atacand Review and Atacand Label ), LASIX (40 Mg, Unk) (View Lasix Review and Lasix Label ), POTASSIUM CHLORIDE (750 Mg, Qd) (View Potassium Chloride Review and Potassium Chloride Label ), MAGNYL (ASPIRIN) (75 Mg, Qd) (View Magnyl (aspirin) Review and Magnyl (aspirin) Label ).

6282134-2 | Pre-eclampsia, Pregnancy
Adverse event was reported on Jul 13, 2009 by a Female patient taking Lumigan (View Usage) (Dosage: Unk, Unk) was diagnosed with glaucoma (What is glaucoma?) and. Location: FRANCE , 34 years of age, Patient had the following side effects: pre-eclampsia, pregnancy (What is pregnancy?). During the same period patient was treated with COSOPT (Unk, Unk) (View Cosopt Review and Cosopt Label ), CARTROL (Unk, Unk) (View Cartrol Review and Cartrol Label ), TIMOPTIC (Unk, Unk) (View Timoptic Review and Timoptic Label ). Patient was hospitalized.

6263684-1 | Instillation Site Irritation
on Jul 09, 2009 Female patient from CANADA , 66 years of age, was treated with Lumigan (View Usage). After Lumigan was administered, patient had the following side effects: instillation site irritation. Lumigan dosage: 1 Gtt, Qhs. During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ).

6259806-9 | Hallucination, Auditory, Tinnitus
on Jul 02, 2009 Female patient from NETHERLANDS , 72 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Lumigan (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, auditory, tinnitus (What is tinnitus?). Lumigan dosage: Unk, Unk. During the same period patient was treated with GANFORT (View Ganfort Review and Ganfort Label ), COSOPT (View Cosopt Review and Cosopt Label ).

6258917-1 | Hypertension, Respiratory Disorder, Tachycardia
Patient was taking Lumigan (View Usage). Patient had the following side effects: hypertension, respiratory disorder, tachycardia on Jul 01, 2009 from GERMANY Additional patient health information: Female patient , 70 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Lumigan dosage: . Patient was hospitalized.